Search
Products
Community
Markets
News
Brokers
More
EN
Get started
Community
/
Ideas
/
SRZN a Penny biotech LONG
Surrozen, Inc.
Long
SRZN a Penny biotech LONG
By AwesomeAvani
Follow
Follow
Updated
Feb 23
1
Feb 21
SRZN has had good momentum. It has no revenues. Clinical trials but a lot of cash. SRZN has
advanced trials underway for a product to treat alcoholic hepatitis presumably settling it down
before it becomes irreversible cirrhosis (only for patients who are alcohol-free) and also useful
for liver metabolic disorders from a genetic basis.
SRZN has been trending up for a week with a bit of a pause in the middle of it. It picked up
60% of its price while breaking out through the anchored VWAP lines and the volume profile.
The far greater market is the former.
It is priced at 90 or more off it's all-time high of about $160. IF it picks up hype from the
last clinical trial getting a report and a calendared review by the, SRZN could reach for that
all time high. This is speculative and risky as are most biotechnology penny stocks. They are
trading news and potential not current net revenues. A small position with room in the stop
loss for the average range and volatility is best. This is a typical high risk higher potential
reward type of trade.
Feb 21
Trade active
One week chart was uploaded in error but does show the all-time high. Linked here
is the 15-minute version
Feb 22
Trade active
AI indicator suggests that price might be topping out later this morning. It has been
a good trade. looking to see if it reverses .
Feb 23
Trade closed: target reached
Reversal arrived and closed in profit.
biotechnology
biotechstocks
clinicalstudy
fdaapproval
LABU
Oscillators
pennystock
Volatility
Volume
XBI
AwesomeAvani
Follow
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the
Terms of Use
.